Preview Of HealthTech At CES 2024: MagicMirror Of Health; Hologram Surgeon; Loud Whispers

At CES Unveiled, which offered members of the media a preview of the latest tech to be presented during the upcoming CES 2024 extravaganza, Medtech Insight spoke with leaders at Nuraologix, Holoconnects and Whispp about their technologies and plans.

CES 2024
• Source: Medtech Insight

Before the official start of the Consumer Electronics Show (CES), the organizers held an event called Unveiled to give the media a sneak peek of what to expect at the world’s biggest tech show, which starts on 9 January. Medtech Insight was on-site to demo and preview some of the tech solutions presented at the event. (Also see "Freshest In Agetech Headed For CES 2024: Meet Your Life-Size Hologram, Experience Being 80, Visit A (Really) Smart Home" - Medtech Insight, 8 December, 2023.)

Nuralogix

Nuralogix Corp, which develops tech solutions for contactless health monitoring, launched a new hardware solution called MagicMirror that allows users to assess 30 health perimeters such as risk of Type 2 diabetes, hypertension, fatty liver disease, stress levels and anxiety health risk within seconds by “simply looking into a mirror.” The platform, called Anura, is powered by NuraLogix’s patented Transdermal Optical Imaging (TIO) technology, a form of remote photoplethysmography that detects a person’s face, identifies key regions of interest and extracts blood flow information that is combined with artificial intelligence data models to assess health perimeters.

“This is an attempt to get into the kiosk business,” NuraLogix’s Vince Traylor, director of sales and partnerships, US, told Medtech Insight. “This can go into a nursing home, a gym, an employer’s office – it’s a complete standalone.”

The MagicMirror is already being sold to businesses in China and is expected to be introduced in the US in the second half of this year. The company is awaiting US Food and Drug Administration clearance for assessing heart rate, respiration and blood pressure, which it expects to receive this year.

Holoconnects

Holoconnects’ CEO Andre Smith awed the media by beaming himself live to the event via the Holobox for a live chat from Amsterdam, thousands of miles from Las Vegas. The Holobox is about the size of a phone booth and displays a full-sized holographic rendering of a person, which gives the illusion of the person being in the same room having a “normal conversation.” That is also the intended use for health care settings, Steve Sterling, Holoconnects’ managing director North America told Medtech Insight.

The company installed two life-sized Holobox displays at Specialty Care Clinics in Dallas to connect orthopedic surgeons via hologram to patients in their clinics for post-surgery follow-ups.

“Doctors can’t always travel to where patients are and particular for non-touch visits, but they still want to have an interaction and they really want the patient to have the sense that they had some engagement,” Sterling explained. He stressed that the solution doesn’t aim to improve outcomes for patients, but rather improve patient engagement. The idea is that the patient will travel to the clinic and get required care by health staff members but also get the experience of a “live-like” conversation with the surgeon who will see the patient using the Holobox.

Whispp

Whispp designed a voice technology to amplify the voice of people who stutter severely and those with vocal disorders such a people with throat cancer or vocal cord paralysis. The founder and CEO of WHISPP Joris Castermans told Medtech Insight he stuttered himself as a child and during high school, which led him to start the Netherlands-based company. The company’s technology works by converting a person’s “whisper” into an amplified, natural-sounding voice.

“It’s language-independent because we’re using AI that’s based on audio compared to current solutions that use speech to text for non-standard speech,” Castermans said. Castermans hopes to partner with tech companies – Google, Apple or Samsung – to bring the voice technology to the US.

After a year of continuous headlines about ChatGPT and AI, CES 2024 promises to continue that trend of showcasing AI-based solutions. Medtech Insight will be on-site in Las Vegas to follow discussions focusing on AI and demo the latest healthtech and other digital health solutions.

More from Business

Abbott’s TriClip Reduces Severity Of Tricuspid Regurgitation Two-Year Results Confirm

 

Abbott presented late-breaking data at the 2025 American College of Cardiology conference demonstrating that TriClip transcatheter edge-to-edge repair offers prolonged patient benefits compared to medical treatment alone after two years, which were not evident at one year.

Exact Sciences Launches Cologuard Plus

 

The Cologuard Plus test has a sensitivity of 95% and a specificity of 94% for the detection of colorectal cancer; “unmatched accuracy,” according to Exact Sciences.

On The Move: New CMO For Oura Health, COO For AbundaBox

 

Leann Sims joins AbundaBox as COO; Oura Ring firm appoints CMO.

LSI 2025: Vektor Medical CEO Says ‘Arrhythmia Is The Biggest Health Care Crisis Nobody Talks About,’ vMap Treats It With 91.1% Accuracy

 
• By 

Vektor Medical is ramping up efforts to bring its vMap technology used to identify arrhythmia sources to more US hospitals, start enrollment in a multinational trial, and commercialize in Europe, pending the CE mark. Medtech Insight sat down with CEO Rob Krummen at LSI 2025 to discuss their plans.

More from Conferences

LSI 2025: Intuitive Surgical CEO Gary Guthart On da Vinci 5’s Force Feedback, Digital Coaching, ION Expansion, And Robotic Surgery’s Future

 
• By 

Medtech Insight sat down with Intuitive Surgical CEO Gary Guthart at the recent LSI USA conference to discuss the full launch of the new da Vinci 5 robotic system and planned digital enhancements. Guthart also offered his views on health care interoperability, AI regulation, outpatient surgeries, autonomous robots, and how the company is harnessing technology to shape the future of robotic surgery.

Urine Test Could Halve Number Of CT Scans For Patients With Kidney Cancer

 

The urine-based GAGome test showed promise in the first clinical results from the international AURORAX-0087A, in the largest study conducted on clear cell renal cell carcinoma, the most common type of kidney cancer.

Wired Health: Women Of Wearables Shares Market Outlook

 

Medtech Insight sat down with Anja Streicher, chief marketing officer at Women of Wearables, a global community offering events and education resources to support the femtech industry, to discuss trends in the women's wearables tech market, challenges and innovators pushing the boundaries.